Investing in Maternal, Newborn and Child Health: The Case for Asia and the Pacific
The analysis in this document has shown that the region needs at least an additional US$5 billion annually by 2010 – increasing to an additional US$10 billion by 2015.
This document presents a case for investment in maternal, newborn, and child health that combines the best available science and economics, based on evidence about what works in practice. The investment case has been developed by analysts from 12 global, multilateral and bilateral organisations and foundations working in the field. The cost estimates will be continually updated as new data becomes available.
- Key Messages
- Investing in Maternal, Newborn and Child Health - The Case for Asia and the Pacific
- Why Invest in Maternal, Newborn and Child Health?
- Why Asia and the Pacific?
- Why is Spending Critical?
- What to Invest in and How Much Will It Cost?
- What is New Here that Gives Me Confidence It Will Work?
- What are the Next Steps?